Segmentation by type classifies the Direct Agglutination Test according to its procedural format, which shapes manufacturing complexity, cost structure, and end‑user adoption. The primary categories are slide‑based agglutination, tube‑based agglutination, and microtiter‑plate agglutination, each offering distinct workflow characteristics. Slide‑based formats, favored for point‑of‑care settings, contribute approximately 40 % of market volume due to their minimal equipment requirements. Tube‑based assays, prevalent in reference laboratories, represent about 35 % of sales, reflecting their robustness for high‑throughput screening. Microtiter‑plate formats, increasingly adopted for automated platforms, account for the remaining 25 % and are projected to grow as laboratories modernize. This type‑level taxonomy elucidates how procedural preferences and infrastructural constraints drive revenue distribution, informing manufacturers’ decisions on product development, scaling, and market entry strategies.